{"count": 4, "results": [{"_id": "36316840", "pmid": 36316840, "pmcid": "PMC9622616", "title": "Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology", "journal": "Medicine (Baltimore)", "authors": ["Huang Y", "Wang X", "Yan C", "Li C", "Zhang L", "Zhang L", "Liang E", "Liu T", "Mao J"], "date": "2022-10-28T00:00:00Z", "doi": "10.1097/MD.0000000000031437", "meta_date_publication": "2022 Oct 28", "meta_volume": "101", "meta_issue": "43", "meta_pages": "e31437", "score": 50251.81, "text_hl": "The effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @DISEASE_Non_alcoholic_Fatty_Liver_Disease @DISEASE_MESH:D065626 @@@NAFLD@@@ mainly related to cytoplasm and protein binding, @DISEASE_Non_alcoholic_Fatty_Liver_Disease @DISEASE_MESH:D065626 @@@NAFLD@@@, @<m>DISEASE_Hepatitis_B</m> @DISEASE_MESH:D006509 @@@hepatitis B@@@, pathway in @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@, toll like receptor signaling pathway and @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ (@DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@). ", "citations": {"NLM": "Huang Y, Wang X, Yan C, Li C, Zhang L, Zhang L, Liang E, Liu T, Mao J. Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology Medicine (Baltimore). 2022 Oct 28;101(43):e31437. PMID: 36316840", "BibTeX": "@article{36316840, title={Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology}, author={Huang Y and Wang X and Yan C and Li C and Zhang L and Zhang L and Liang E and Liu T and Mao J}, journal={Medicine (Baltimore)}, volume={101}, number={43}, pages={e31437}}"}}, {"_id": "25674734", "pmid": 25674734, "pmcid": "PMC4602747", "title": "Cancer Risk in HBV Patients With Statin and Metformin Use", "journal": "Medicine (Baltimore)", "authors": ["Chen CI", "Kuan CF", "Fang YA", "Liu SH", "Liu JC", "Wu LL", "Chang CJ", "Yang HC", "Hwang J", "Miser JS", "Wu SY"], "date": "2015-02-01T00:00:00Z", "doi": "10.1097/MD.0000000000000462", "meta_date_publication": "2015 Feb", "meta_volume": "94", "meta_issue": "6", "meta_pages": "e462", "score": 50060.67, "text_hl": "This is the first article suggesting a synergistic protective effect of using both statin and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Hepatitis_B</m> @DISEASE_MESH:D006509 @@@HBV infection@@@. ", "citations": {"NLM": "Chen CI, Kuan CF, Fang YA, Liu SH, Liu JC, Wu LL, Chang CJ, Yang HC, Hwang J, Miser JS, Wu SY. Cancer Risk in HBV Patients With Statin and Metformin Use Medicine (Baltimore). 2015 Feb;94(6):e462. PMID: 25674734", "BibTeX": "@article{25674734, title={Cancer Risk in HBV Patients With Statin and Metformin Use}, author={Chen CI and Kuan CF and Fang YA and Liu SH and Liu JC and Wu LL and Chang CJ and Yang HC and Hwang J and Miser JS and Wu SY}, journal={Medicine (Baltimore)}, volume={94}, number={6}, pages={e462}}"}}, {"_id": "24164660", "pmid": 24164660, "title": "Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells.", "journal": "J Viral Hepat", "authors": ["Xun YH", "Zhang YJ", "Pan QC", "Mao RC", "Qin YL", "Liu HY", "Zhang YM", "Yu YS", "Tang ZH", "Lu MJ", "Zang GQ", "Zhang JM"], "date": "2014-08-01T00:00:00Z", "doi": "10.1111/jvh.12187", "meta_date_publication": "2014 Aug", "meta_volume": "21", "meta_issue": "8", "meta_pages": "597-603", "score": 50045.918, "text_hl": "Hepatitis B virus surface antigen (HBsAg) plays an important role in maintaining the tolerance and may interfere with host innate and adaptive immune responses; therefore, novel therapeutic strategies to reduce HBsAg loads in @SPECIES_9606 @@@patients@@@ infected with @SPECIES_10407 @@@hepatitis B virus@@@ (@SPECIES_10407 @@@HBV@@@) are emerging as an attractive but challenging issue. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ could regulate hepatic metabolism while the latter interacts with @<m>DISEASE_Hepatitis_B</m> @DISEASE_MESH:D006509 @@@HBV infection@@@. ", "citations": {"NLM": "Xun YH, Zhang YJ, Pan QC, Mao RC, Qin YL, Liu HY, Zhang YM, Yu YS, Tang ZH, Lu MJ, Zang GQ, Zhang JM. Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells. J Viral Hepat. 2014 Aug;21(8):597-603. PMID: 24164660", "BibTeX": "@article{24164660, title={Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells.}, author={Xun YH and Zhang YJ and Pan QC and Mao RC and Qin YL and Liu HY and Zhang YM and Yu YS and Tang ZH and Lu MJ and Zang GQ and Zhang JM}, journal={J Viral Hepat}, volume={21}, number={8}, pages={597-603}}"}}, {"_id": "31734994", "pmid": 31734994, "title": "[Study on the risk of hepatitis B-related cirrhosis combined with type 2 diabetes mellitus for the occurrence of primary hepatocellular carcinoma].", "journal": "Zhonghua Gan Zang Bing Za Zhi", "authors": ["Zhang LL", "Li YF", "Zhang C", "Wu XF", "Ma Y", "Li L"], "date": "2019-10-20T00:00:00Z", "doi": "10.3760/cma.j.issn.1007-3418.2019.10.010", "meta_date_publication": "2019 Oct 20", "meta_volume": "27", "meta_issue": "10", "meta_pages": "788-792", "score": 50043.297, "text_hl": "Methods: A retrospective case-control study was conducted. (1) 325 cases with @<m>DISEASE_Hepatitis_B</m> @DISEASE_MESH:D006509 @@@hepatitis B@@@-related @DISEASE_Fibrosis @DISEASE_MESH:D005355 @@@cirrhosis@@@ complicated with @DISEASE_Carcinoma_Hepatocellular @DISEASE_MESH:D006528 @@@primary hepatocellular carcinoma@@@ were selected as the study group and 601 @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Hepatitis_B</m> @DISEASE_MESH:D006509 @@@hepatitis B cirrhosis@@@ as the control group. ", "citations": {"NLM": "Zhang LL, Li YF, Zhang C, Wu XF, Ma Y, Li L. [Study on the risk of hepatitis B-related cirrhosis combined with type 2 diabetes mellitus for the occurrence of primary hepatocellular carcinoma]. Zhonghua Gan Zang Bing Za Zhi. 2019 Oct 20;27(10):788-792. PMID: 31734994", "BibTeX": "@article{31734994, title={[Study on the risk of hepatitis B-related cirrhosis combined with type 2 diabetes mellitus for the occurrence of primary hepatocellular carcinoma].}, author={Zhang LL and Li YF and Zhang C and Wu XF and Ma Y and Li L}, journal={Zhonghua Gan Zang Bing Za Zhi}, volume={27}, number={10}, pages={788-792}}"}}]}